Unpublished results from the first phase II trial with the triple combination of semaglutide, cilofexor and/or firsocostat treatment for 24 weeks in 108 patients with NASH showed significant improvements in hepatic steatosis (measured with MRI) and liver injury (measured by serum alanine aminotransferase) in the combination treatment arm vs semaglutide monotherapy (56)
Institutions rely on strict medication protocols and centralized formularies, making them the default supply point for chronic care
When to Consult a Doctor There are several indications that its time to speak with your doctor about your GLP-1 side effects, says Carroll
Triple fixed drug combinations in type 2 diabetes
While exact dosing varies, the microdosing GLP-1 approach generally includes: Starting with a lower dose than standard treatment (such as Ozempic or Mounjaro) to allow the body to adjust Gradual adjustments over time based on tolerance, appetite changes, and results Monitoring appetite, digestion, and energy levels to guide dosing decisions Tracking weight and overall progress to ensure the approach is effective Because GLP-1 medications affect metabolism and blood sugar, this approach should always be individualized
Despite strong marketing claims, commercial GLP-1 patches contain no actual GLP-1 medication and cant deliver weight loss results comparable to those of prescription injections
